Related references
Note: Only part of the references are listed.EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid Leukemia
Marius Bill et al.
CLINICAL CANCER RESEARCH (2020)
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Mesenchymal PGD2 activates an ILC2-Treg axis to promote proliferation of normal and malignant HSPCs
Limei Wu et al.
LEUKEMIA (2020)
Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity
Huang Zhu et al.
CELL STEM CELL (2020)
Phase II trial of CPX-351 in patients with acute myeloid leukemia at high risk for induction mortality
Ghayas C. Issa et al.
LEUKEMIA (2020)
Notch Regulates Innate Lymphoid Cell Plasticity during Human NK Cell Development
Ansel P. Nalin et al.
JOURNAL OF IMMUNOLOGY (2020)
Plasticity of innate lymphoid cell subsets
Suzanne M. Bal et al.
NATURE REVIEWS IMMUNOLOGY (2020)
IL-17-Producing Cells in Tumor Immunity: Friends or Foes?
Da-Sol Kuen et al.
IMMUNE NETWORK (2020)
Investigation of donor KIR content and matching in children undergoing hematopoietic cell transplantation for acute leukemia
Michael R. Verneris et al.
BLOOD ADVANCES (2020)
Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial
Juliette Lambert et al.
HAEMATOLOGICA (2019)
Will CAR T cell therapy have a role in AML? Promises and pitfalls
Katherine D. Cummins et al.
SEMINARS IN HEMATOLOGY (2019)
Hide and seek: Plasticity of innate lymphoid cells in cancer
Tobias Bald et al.
SEMINARS IN IMMUNOLOGY (2019)
True Detective: Unraveling Group 1 Innate Lymphocyte Heterogeneity
Luke Riggan et al.
TRENDS IN IMMUNOLOGY (2019)
The Obese Liver Environment Mediates Conversion of NK Cells to a Less Cytotoxic ILC1-Like Phenotype
Antonia O. Cuff et al.
FRONTIERS IN IMMUNOLOGY (2019)
BMT CTN 1803: Haploidentical Natural Killer Cells (CSTD002) to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM)
Sumithira Vasu et al.
BLOOD (2019)
Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
Courtney D. DiNardo et al.
BLOOD (2019)
An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer
Steven Feins et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia
Sarah Cooley et al.
BLOOD ADVANCES (2019)
CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML
Berengere Salome et al.
BLOOD ADVANCES (2019)
Donor and host coexpressing KIR ligands promote NK education after allogeneic hematopoietic stem cell transplantation
Xiang-Yu Zhao et al.
BLOOD ADVANCES (2019)
Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity
E. Liu et al.
LEUKEMIA (2018)
Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML
Andreas T. Bjorklund et al.
CLINICAL CANCER RESEARCH (2018)
The aryl hydrocarbon receptor modulates the function of human CD56bright NK cells
Uriel Y. Moreno-Nieves et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
Natural Killer Cell Education and the Response to Infection and Cancer Therapy: Stay Tuned
Jeanette E. Boudreau et al.
TRENDS IN IMMUNOLOGY (2018)
Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities
Jae Eun Cheong et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Abnormal populations and functions of natural killer cells in patients with myelodysplastic syndromes
Wei Zhang et al.
ONCOLOGY LETTERS (2018)
The Notch Signaling Pathway Is Balancing Type 1 Innate Lymphoid Cell Immune Functions
Thibaut Perchet et al.
FRONTIERS IN IMMUNOLOGY (2018)
Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and function
Steven D. Scoville et al.
BLOOD (2018)
Innate Lymphoid Cells: 10 Years On
Eric Vivier et al.
CELL (2018)
Aryl Hydrocarbon Receptor Signaling Cell Intrinsically Inhibits Intestinal Group 2 Innate Lymphoid Cell Function
Shiyang Li et al.
IMMUNITY (2018)
Natural killer cells and other innate lymphoid cells in cancer
Laura Chiossone et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors
Seishi Kyoizumi et al.
JOURNAL OF IMMUNOLOGY (2017)
Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL
Corinna L. Boeck et al.
JOURNAL OF IMMUNOTHERAPY (2017)
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis
Sara Trabanelli et al.
NATURE COMMUNICATIONS (2017)
NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
Anne-Sophie Chretien et al.
ONCOTARGET (2017)
Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia
Anne-Sophie Chretien et al.
FRONTIERS IN IMMUNOLOGY (2017)
NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML
Anne-Sophie Chretien et al.
ONCOIMMUNOLOGY (2017)
ILC1 Confer Early Host Protection at Initial Sites of Viral Infection
Orr-El Weizman et al.
CELL (2017)
Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation
Stefan O. Ciurea et al.
BLOOD (2017)
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
Yulong Gao et al.
NATURE IMMUNOLOGY (2017)
Successful Transfer of Umbilical Cord Blood CD34+ Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia Patients
Harry Dolstra et al.
CLINICAL CANCER RESEARCH (2017)
Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation
Ai Ing Lim et al.
CELL (2017)
The aryl hydrocarbon receptor is required for the maintenance of liver-resident natural killer cells
Luhua H. Zhang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
Rizwan Romee et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Vinit Kumar et al.
TRENDS IN IMMUNOLOGY (2016)
Acute myeloid leukaemia
Asim Khwaja et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
NK cells and cancer: you can teach innate cells new tricks
Maelig G. Morvan et al.
NATURE REVIEWS CANCER (2016)
CD127+ innate lymphoid cells are dysregulated in treatment naive acute myeloid leukemia patients at diagnosis
Sara Trabanelli et al.
HAEMATOLOGICA (2015)
The biology of innate lymphoid cells
David Artis et al.
NATURE (2015)
Acute Myeloid Leukemia
Hartmut Doehner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The Aryl Hydrocarbon Receptor Antagonist StemRegenin1 Improves In Vitro Generation of Highly Functional Natural Killer Cells from CD34+ Hematopoietic Stem and Progenitor Cells
Mieke W. H. Roeven et al.
STEM CELLS AND DEVELOPMENT (2015)
CD127+ innate lymphoid cells are dysregulated in treatment naive acute myeloid leukemia patients at diagnosis
Sara Trabanelli et al.
HAEMATOLOGICA (2015)
Increased NK cell maturation in patients with acute myeloid leukemia
Anne-Sophie Chretien et al.
FRONTIERS IN IMMUNOLOGY (2015)
Expression of indoleamine 2,3-dioxygenase in leukemic cells indicates an unfavorable prognosis in acute myeloid leukemia patients with intermediate-risk cytogenetics
Kenji Fukuno et al.
LEUKEMIA & LYMPHOMA (2015)
Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer Cells
Jeffrey W. Leong et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease
J. Marius Munneke et al.
BLOOD (2014)
Th17 cells and interleukin-17 increase with poor prognosis in patients with acute myeloid leukemia
Yixiang Han et al.
CANCER SCIENCE (2014)
The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemia
J-N Gong et al.
CELL DEATH AND DIFFERENTIATION (2014)
Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia
Kate Stringaris et al.
HAEMATOLOGICA (2014)
Involvement of the Kynurenine Pathway in Human Glioma Pathophysiology
Seray Adams et al.
PLOS ONE (2014)
Human natural killer cell development in secondary lymphoid tissues
Aharon G. Freud et al.
SEMINARS IN IMMUNOLOGY (2014)
The Transcription Factor AHR Prevents the Differentiation of a Stage 3 Innate Lymphoid Cell Subset to Natural Killer Cells
Tiffany Hughes et al.
CELL REPORTS (2014)
Adoptive T-cell therapy: adverse events and safety switches
Siok-Keen Tey
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2014)
CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia
Margaret L. Green et al.
BLOOD (2013)
Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56bright subset
Emily M. Mace et al.
BLOOD (2013)
Notch activation inhibits AML growth and survival: a potential therapeutic approach
Sankaranarayanan Kannan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor
June Ho Shin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Location and cellular stages of natural killer cell development
Jianhua Yu et al.
TRENDS IN IMMUNOLOGY (2013)
Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function
Bree Foley et al.
BLOOD (2012)
Transcriptional control of innate lymphoid cells
Jenny Mjosberg et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Interleukin-22 Protects Intestinal Stem Cells from Immune-Mediated Tissue Damage and Regulates Sensitivity to Graft versus Host Disease
Alan M. Hanash et al.
IMMUNITY (2012)
miR-29ab1 Deficiency Identifies a Negative Feedback Loop Controlling Th1 Bias That Is Dysregulated in Multiple Sclerosis
Kristen M. Smith et al.
JOURNAL OF IMMUNOLOGY (2012)
Natural killer cell immune escape in acute myeloid leukemia
E. Lion et al.
LEUKEMIA (2012)
AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch
Jacob S. Lee et al.
NATURE IMMUNOLOGY (2012)
Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
Cecele J. Denman et al.
PLOS ONE (2012)
Innate Lymphoid Cells Promote Anatomical Containment of Lymphoid-Resident Commensal Bacteria
Gregory F. Sonnenberg et al.
SCIENCE (2012)
Pre-eminence and persistence of immature natural killer cells in acute myeloid leukemia patients in first complete remission
Nicolas Dauguet et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients
Ahmet H. Elmaagacli et al.
BLOOD (2011)
MicroRNA-29 Regulates T-Box Transcription Factors and Interferon-γ Production in Helper T Cells
David F. Steiner et al.
IMMUNITY (2011)
CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia
S. J. Coles et al.
LEUKEMIA (2011)
Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)
Pia Ostergaard et al.
NATURE GENETICS (2011)
Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia
Christopher N. Hahn et al.
NATURE GENETICS (2011)
Innate or Adaptive Immunity? The Example of Natural Killer Cells
Eric Vivier et al.
SCIENCE (2011)
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Hartmut Doehner et al.
BLOOD (2010)
Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors
Miroslaw J. Szczepanski et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Loss of natural killer activity as an indicator of relapse in acute leukaemia
J. A. TRATKIEWICZ et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Evidence for Ligand-Mediated Selective Modulation of Aryl Hydrocarbon Receptor Activity
Iain A. Murray et al.
MOLECULAR PHARMACOLOGY (2010)
Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells
Anthony E. Boitano et al.
SCIENCE (2010)
MicroRNA 29b functions in acute myeloid leukemia
Ramiro Garzon et al.
BLOOD (2009)
An unusual CD56bright CD16low NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation
Nicolas Dulphy et al.
JOURNAL OF IMMUNOLOGY (2008)
Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors
Pearlie K. Epling-Burnette et al.
BLOOD (2007)
CD56bright CD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation
Chiara Romagnani et al.
JOURNAL OF IMMUNOLOGY (2007)
Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction
Cyril Fauriat et al.
BLOOD (2007)
Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+ CD25+ regulatory T cells
H Zhang et al.
NATURE MEDICINE (2005)
Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes
KC Hsu et al.
BLOOD (2005)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells
AG Freud et al.
IMMUNITY (2005)
Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells
MW Lowdell et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Share Paper
